جستجوی استاد راهنمای دانشگاهی

Margaret Bublitzمشاهده پروفایل

دانشیار

• Perinatal Mental Health
• Integrated Behavioral Health
• Mindfulness-Based Interventions
• +۶ مورد دیگر

Margaret Bublitz is Associate Professor at Brown University with joint appointments in the Department of Psychiatry and Human Behavior , Department of Medicine , and Department of Obstetrics and Gynecology . She holds secondary appointments at the School of Public Health as Senior Investigator and Behavioral and Social Sciences faculty member. Dr. Bublitz earned her PhD in Clinical Psychology (2010) from the University of British Columbia, followed by postdoctoral training in Cardiovascular Behavioral Medicine at Brown Medical School. Her research focuses on: Psychological stress pathways to adverse perinatal outcomes Maternal childhood maltreatment effects on neurobiology Mindfulness interventions for hypertension and preterm birth prevention Her 15 most recent publications demonstrate expertise in perinatal mental health , sleep-disordered breathing , HPA axis regulation , and fetal neurodevelopment , with significant collaborations in neuroendocrinology and maternal-infant health disparities . Scientific recognition includes: 2024-2025 Global Fulbright Scholarship 2022 Brown Early Career Research Achievement Award Multiple NIH and foundation grants exceeding $6 million Bublitz leads NIH-funded projects examining mechanisms of mindfulness training (R01HL157288) and serves as mentor in the MORPHE Trial for digital maternal health innovations. She is a licensed psychologist and active member of Brown's Stress, Trauma and Resilience (STAR) Institute and Mindfulness Center .

• Obstetrics
• Maternal and Neonatal Outcomes
• Epidemiology
• +۱۲ مورد دیگر

Jessica Illuzzi is the Deputy Dean for Education and Harold W. Jockers Professor of Medical Education at the Yale School of Medicine, where she is also a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences. She plays a pivotal role in medical education leadership, curriculum development, and accreditation efforts, while maintaining an active research program in maternal and neonatal health. Harvard University, AB in Biochemical Sciences (1994) Harvard Medical School, MD (1998) Yale School of Graduate Studies, MS in Epidemiology (2006) Residency in Obstetrics and Gynecology, Yale-New Haven Hospital (2002) Her research focuses on the impact of obstetric interventions on maternal and neonatal outcomes, especially among low-risk women. Key areas include cesarean section, vaginal birth after cesarean (VBAC), group B streptococcus prophylaxis, and innovative maternity care models. She has led studies on labor management, health disparities, and quality improvement in obstetric care. Recent publications highlight trends in racial and ethnic disparities in maternal outcomes, validation of VBAC prediction tools, neonatal resuscitation guidelines, and integrated maternal-child care models in Haiti. Her work spans clinical epidemiology, health services research, and digital health interventions in obstetrics. Hellman Award (2017) Leah Lowenstein Award (2010) Roy M. Pitkin Award (2010) Bohmfalk Award (2007) Association of Professors of Gynecology and Obstetrics Teaching Award (2006) Dr. Illuzzi has been a strong advocate for medical education reform and student mentorship. She previously served as clerkship director and curriculum director, and has played key roles in Yale’s curriculum redesign and LCME reaccreditation. She has also led quality improvement initiatives in labor care and contributed to national guidelines on neonatal resuscitation. Her collaborative research network includes frequent co-authors such as Xiao Xu and Katherine Harper Campbell.

Tinnakorn Chaiworapongsaمشاهده پروفایل

استاد

• Angiogenic/anti-angiogenic factors
• Biomarkers in obstetrical syndromes
• Fetal death
• +۳ مورد دیگر

Tinnakorn Chaiworapongsa, M.D., is a Professor and Director of the Maternal-Fetal Medicine Fellowship Program at Wayne State University School of Medicine's Department of Obstetrics and Gynecology. His primary affiliations include leadership in perinatal research and clinical education at Detroit Medical Center/Wayne State University. Education: M.D. from Chulalongkorn University, Bangkok, Thailand (1988) Residency in Obstetrics and Gynecology at Pramongkutklao Hospital, Mahidol University (1994) Research Fellowship at Perinatology Research Branch, NICHD/NIH (2000-2003) Clinical Fellowship in Maternal-Fetal Medicine at Wayne State University (2007-2010) Research Focus: Dr. Chaiworapongsa investigates angiogenic/anti-angiogenic imbalances in obstetrical syndromes, biomarkers for preeclampsia and preterm labor, mechanisms of fetal death, and angiogenesis in recurrent pregnancy loss. His work bridges molecular pathophysiology with clinical diagnostics. Professional Leadership: Previously served as Director of the Biomarker Unit at NICHD/NIH (2011-2015) and Section Head for Biomarkers of Great Obstetrical Syndromes. Current role emphasizes fellowship training and translational research. Awards: March of Dimes Award for Prematurity Research (2010) Multiple Research Excellence Awards from Wayne State University (2008, 2009) Frederick Zuspan Awards from ISSHP (2008, 2014) Young Investigator and Poster Awards from obstetrics societies

Lars Engstrandمشاهده پروفایل

استاد

• Microbiome Research
• Women's Reproductive Health
• Gastroenterology
• +۷ مورد دیگر

Lars Engstrand is a Professor in infection control at Karolinska Institutet, heading the Translational Microbiome Research and Pandemic Preparedness group within the Department of Microbiology, Tumor and Cell Biology. His research spans multiple disciplines with a focus on translational microbiome research and pandemic preparedness. Engstrand's research interests center on understanding the human microbiome's role in health and disease, particularly in women's reproductive health and gastroenterology. His group has established multiple large-scale clinical studies including SweMaMi (Swedish Maternal Microbiome project), BASIC (associations between microbiota and preterm birth), VaMiGyn (Vaginal Microbiota in Gynaecological health), and several others investigating the vaginal microbiome's relationship to pregnancy outcomes, HPV infection, and cervical cancer. His team also conducts significant research on gut microbiome in inflammatory bowel disease and colorectal conditions through projects like PopCol and KOLBIBAKT. Analysis of Engstrand's most recent publications reveals a strong focus on the relationship between microbiome composition and women's health outcomes. His research consistently examines how vaginal, gut, and oral microbiomes influence pregnancy complications, preterm birth, HPV infection, and mental health during pregnancy. The work often employs large cohort studies with comprehensive sampling strategies across multiple body sites and time points, providing robust data for understanding microbiome dynamics in health and disease. Engstrand leads the Microbiome Exploration and Development for Intervention (MEDI) initiative and the National Pandemic Center (NPC) at Karolinska Institutet. The NPC conducted large-scale sequencing during the COVID-19 pandemic and has amassed over 1.5 million samples. His research group includes multiple specialized teams focusing on culturomics, bioinformatics, labcore operations, women's health research, and pandemic preparedness.

Christian Lindhمشاهده پروفایل

دانشیار

• Occupational Health
• Environmental Health
• Analytical Chemistry
• +۵ مورد دیگر

Christian Lindh is an active Associate Professor and Senior Lecturer at Lund University's Division of Occupational and Environmental Medicine. He serves as Research Team Manager for Applied Mass Spectrometry in Environmental Medicine and is affiliated with EpiHealth: Epidemiology for Health. His research focuses on environmental and occupational exposures and their health impacts, with particular expertise in biomonitoring and analytical chemistry. His research interests span Occupational Health , Environmental Health , Analytical Chemistry , Exposure Assessment , and Epidemiology . Lindh specializes in studying human exposure to environmental pollutants including PFAS, heavy metals, phthalates, and polycyclic aromatic hydrocarbons, with particular focus on vulnerable populations such as pregnant women and children. His work contributes to UN Sustainable Development Goals related to health and environmental protection. Analysis of his recent publications reveals a strong focus on environmental epidemiology, particularly examining PFAS exposure patterns, heavy metal toxicity, and the health impacts of environmental contaminants across different life stages. His research employs advanced analytical techniques, particularly mass spectrometry, to precisely measure exposure levels and investigate dose-response relationships. Lindh has secured significant research funding, currently leading projects including 'Temporal Trends in Lead, Mercury, and Cadmium Levels in Children' (Swedish Environmental Protection Agency, 2025-2026) and 'Trade-offs between food safety and food security' (FORMAS, 2024-2027). He serves as Principal Investigator on multiple active research projects totaling 15, with 7 currently active and 7 completed. As Manager of the 'Targeted Exposomics at Lund University' infrastructure, Lindh leads the Applied Mass Spectrometry in Environmental Medicine research team. His work bridges analytical chemistry with public health research, developing methodologies to assess human exposure to environmental chemicals and evaluating their health consequences through epidemiological studies.

• Multiple Myeloma
• Lymphoma
• Thalassemia
• +۵ مورد دیگر

Professor Joy Ho is a Clinical Professor of Medicine at the University of Sydney’s Central Clinical School and a Senior Staff Specialist in Haematology at Royal Prince Alfred Hospital (RPAH). She serves as Director of Research and Head of the Multiple Myeloma Research Unit and Thalassemia/Haemoglobinopathy Unit at the Institute of Haematology, RPAH. Her research focuses on multiple myeloma, lymphoma, thalassemia, and iron metabolism, with a strong emphasis on clinical trials and translational medicine. She has led numerous multi-centre trials, including pioneering studies on CAR-T cell therapy for lymphoma and novel therapies for myeloma. Prof Ho’s education includes MB.BS. (Hons) from Sydney, D.Phil (Oxford), and fellowships from the Royal Australasian College of Physicians (RACP) and Royal College of Pathologists of Australasia (RCPA). She has held leadership roles in major hematology organizations, including the International Myeloma Working Group (IMWG) and the American Society of Hematology (ASH). Her international collaborations span Singapore, Thailand, and the United States. Her research interests include: Multiple Myeloma: Developing therapies targeting tumor microenvironment and immune modulation. Lymphoma: Pioneering CAR-T cell therapy in Australia. Thalassemia: Gene therapy and iron chelation advancements, including the landmark Northstar trial. Iron Metabolism: Investigating hepcidin and its role in transfusion-dependent anemias. Her recent publications highlight breakthroughs in CAR-T efficacy, myeloma biomarkers, and thalassemia management. Awards include the 2019 Sydney Local Health District Clinical Trial Award and election to the International Myeloma Society Board. She has secured over $2 million in grants for cutting-edge equipment and research. Prof Ho’s academic contributions extend to teaching and supervision, training fellows for RACP/RCPA certifications. Her leadership in national registries (e.g., Australian Haemoglobinopathy Registry) and guidelines (e.g., iron chelation protocols) underscores her commitment to advancing hematology care globally.

Jeffrey T. Jensenمشاهده پروفایل

استاد

• Contraception
• Reproductive Health
• Translational Research
• +۲ مورد دیگر

Jeffrey T. Jensen, M.D., M.P.H., is the Leon Speroff Professor and Vice Chair for Research in the Department of Obstetrics and Gynecology at Oregon Health & Science University (OHSU). He holds joint appointments as Professor of Public Health and Preventive Medicine and serves as a Core Scientist at the Oregon National Primate Research Center (ONPRC). Dr. Jensen completed his medical degree at Emory University, a Master of Public Health at the University of Washington, and residency training at OHSU. Research Focus: Dr. Jensen leads translational and clinical research programs focused on contraceptive innovation. His work emphasizes nonhuman primate models to develop: Novel contraceptive agents targeting oocyte-specific pathways Non-surgical permanent contraception methods Optimized emergency contraception for diverse populations He directs OHSU's Women’s Health Research Unit and the Gates Foundation-funded Oregon Permanent Contraception Research Center (OPERM). Recent Publications: His 15 most recent articles (2023-2025) demonstrate concentrated expertise in: Advanced hormonal contraceptive formulations (IUDs, vaginal rings, oral agents) Weight-adjusted dosing strategies for emergency contraception Biomarker validation for contraceptive efficacy monitoring Real-world assessment of bleeding pattern management Leadership & Collaboration: Dr. Jensen is Principal Investigator of the NICHD Contraception Clinical Trials Network and collaborates with global health organizations (CONRAD, FHI360, Population Council). He serves as Deputy Editor for the journal Contraception and consults for multiple pharmaceutical companies on product development.

Jacqueline Woernerمشاهده پروفایل

دانشیار

• Gender-Based Violence
• Substance Use
• Sexual Risk Behavior
• +۳ مورد دیگر

Jacqueline Woerner is Associate Professor in Sociology and Psychology at the University of Central Florida, where she directs the Social Theory, Relationships, and Interpersonal Violence Exposure (STRIVE) Lab. Her research examines the intersection of gender-based violence, substance use, and health risk behaviors. Education includes: PhD in Social Psychology from Wayne State University BS in Psychology from Appalachian State University Her NIH-funded research investigates how violence victimization relates to health behaviors through motivational frameworks. Current projects examine technology-facilitated sexual violence on dating apps and alcohol's role in intimate partner cyber abuse. She employs diverse methods including surveys, experiments, and daily diaries. As member of the Violence Against Women Faculty Cluster, she develops prevention strategies addressing sexual violence and health disparities. Funded projects include NIJ grants examining transitional housing models for domestic violence survivors. Honors include Rising Star Award for undergraduate mentoring and multiple teaching awards. She serves on editorial boards for Psychology of Violence and leads NIH-funded projects on dating app-facilitated violence.

Angela Birnbaumمشاهده پروفایل

استاد

• Pharmacokinetics
• Clinical Pharmacology
• Neuropharmacology
• +۷ مورد دیگر

Angela Birnbaum is a Professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota College of Pharmacy. She serves as Associate Director of the Center for Clinical and Cognitive Neuropharmacology and is a Fellow of The American Epilepsy Society (FAES). Her research focuses on translational clinical pharmacology with emphasis on special populations including the elderly, pregnant women, children, and those with drug addiction. Dr. Birnbaum earned her PhD in Pharmacology (with a Neuroscience minor) from the University of Minnesota Department of Pharmacology. She completed her undergraduate studies with a Bachelor of Science and Medical Technology (BSMT) with chemistry minor from Ohio Northern University, along with a Bachelor of Biology (BS). She also completed a Medical Technology Internship at St. Rita's Medical Center and a Post-doctoral Fellowship in Clinical Neuropharmacology at the University of Minnesota. Her research program centers on pharmacokinetics and pharmacodynamics in special populations, with particular expertise in antiepileptic drugs. She investigates drug concentration variability and response across different patient groups, with significant work on medications like lamotrigine, carbamazepine, and lacosamide. Her laboratory operates as a Pharmacokinetics Laboratory Core for various grant projects and explores drug stability both in vivo and in vitro. Dr. Birnbaum's recent publications demonstrate a strong focus on pregnancy-related pharmacokinetics, particularly for antiepileptic medications, and pharmacokinetic considerations for vulnerable populations including neonates and critically ill patients. Her work combines pharmacometric modeling with clinical research to optimize drug dosing across diverse patient populations. Among her notable recognitions: Fellow of The American Epilepsy Society (FAES) Designation as Center of Excellence for Model-based Drug Development (MBDD) Certara Center of Excellence designation for her program Dr. Birnbaum has been principal investigator and collaborator on numerous research projects funded by the National Institutes of Health, pharmaceutical industry, instrumentation companies, and foundations. Her current projects include investigations into antiseizure medication exposure during pregnancy and breastfeeding, development of monoclonal antibodies to reverse fentanyl overdose, and clinical trials of multivalent opioid vaccine components. Her laboratory, the Birnbaum Laboratory for Translational Clinical Neuropharmacology, operates as both an independent research program investigating drug effects on cognition and a Pharmacokinetics Laboratory Core supporting multiple research projects. The lab incorporates Certara's Phoenix software suite into thesis and research projects, reflecting their expertise in model-based drug development.

Jennifer Evansمشاهده پروفایل

مدرس ارشد

• Early Modern History
• History of Medicine
• Gender History
• +۴ مورد دیگر

Dr. Jennifer Evans is a Senior Lecturer in History within the School of Creative Arts at the University of Hertfordshire. Her academic career spans over a decade since completing her PhD at the University of Exeter in 2011, followed by two years of teaching there before joining Hertfordshire. She serves as the founding editor of the Early Modern Medicine blog and co-directs the Perceptions of Pregnancy research network with colleagues Leanne Calvert, Sarah Fox, and Chelsea Phillips. Her research focuses on the history of the body, medicine, and gender during 1550-1750, with particular emphasis on reproductive health, infertility, and miscarriage. Her scholarly work demonstrates deep engagement with both male and female experiences of health and sexuality in early modern England. Current projects include 'Wounded Wombs and Empty Cradles: Miscarriage and Pregnancy Loss in Early Modern England c.1600-1780' (Folger Shakespeare Library, 2025-2026) and 'Foraging for Early Modern Medicines 1600-1750' (AHRC-funded). Analysis of her recent publications reveals consistent thematic concentration on bodily experiences, particularly reproductive health across genders. Her work bridges medical history with gender studies, examining how bodily functions and dysfunctions intersected with social structures. The scholarship shows increasing attention to male experiences of reproductive health alongside traditional focus on women's histories, reflecting broader historiographical shifts toward more inclusive medical history. Dr. Evans actively supervises postgraduate students including Kiran Seera (PhD: 'Domestic Disorder: Crime, Kinship, and Space in Bedfordshire, c. 1650-1790') and has completed supervision of three PhD and two MA students. Her research has received substantial external funding including AHRC Early Stage Impact Accelerator Award funding for her foraging project that explores historical medicinal plant knowledge. She directs the Perceptions of Pregnancy researchers' network which has published two major collections and hosted multiple conferences. The network brings together scholars examining all aspects of fertility, pregnancy, childbirth and early parenthood from the seventeenth to twentieth century. Her public engagement includes numerous media appearances including BBC Radio 4's 'The Food Programme' (February 2024), BBC World Service's 'The Food Chain', and multiple television appearances.

Harald Tauchmannمشاهده پروفایل

استاد

• Health Economics
• Empirical Health Economics
• Health Insurance
• +۳ مورد دیگر

Prof. Dr. Harald Tauchmann is a Professor of Health Economics at Friedrich-Alexander University Erlangen-Nuremberg (FAU), where he has held a faculty position since 2013. He is affiliated with the School of Business, Economics and Social Sciences, specifically within the Department of Economics. Prof. Tauchmann also participates in multiple research focus areas at FAU, including 'Insurance and Risk' and 'Work in Transition,' demonstrating his interdisciplinary approach to health economics. Prof. Tauchmann received his education at Heidelberg University and the University of Manchester, UK, where he studied economics, political science, and sociology. He graduated in 1998 and completed his doctorate at the Interdisciplinary Institute for Environmental Economics (University of Heidelberg) in 2003. Prior to joining FAU, he worked as a research associate at the Rhineland-Westphalian Institute for Economic Research (RWI) in Essen from 2003 to 2012 and headed a junior research group at the health economics research center CINCH at the University of Duisburg-Essen. His research expertise lies in empirical health economics, with a particular emphasis on health insurance choice and competition, as well as individual health behavior. He has made significant contributions to understanding obesity, health shocks, mental health care payment systems, and thyroid diagnostics through his extensive publication record. His methodological work includes developing specialized Stata modules for econometric analysis, which have been widely adopted by researchers in the field. Prof. Tauchmann's scholarly work demonstrates a consistent focus on applying rigorous econometric methods to pressing health policy questions. His research portfolio shows particular strength in causal analysis of health behavior, especially regarding obesity interventions, health insurance market dynamics, and the economic consequences of health shocks. His recent publications (including several forthcoming in 2025) indicate continued scholarly productivity and relevance to current health policy debates. From March 2021 to April 2022, Prof. Tauchmann served as chairman of the German Society for Health Economics, highlighting his leadership and recognition within the national health economics community. His email contact is harald.tauchmann@fau.de for professional inquiries.

Ulla McKnightمشاهده پروفایل

استادیار

• Sociology of Health and Illness
• Racialised Health Inequalities
• Gender and Health
• +۱۲ مورد دیگر

Dr Ulla McKnight is an Assistant Professor in Sociology (Sociology and Criminology) at the University of Sussex, School of Law, Politics and Sociology. Her interdisciplinary research focuses on racialised and gendered health inequalities, particularly in reproductive and sexual health for ethnic minority and migrant women in the UK. Her educational background includes a PhD in Sociology from Goldsmiths, University of London (2016), an MA in Postcolonial Studies (Goldsmiths, 2006), a BFA in Photography (San Francisco Art Institute, 2001), and a Postgraduate Certificate in Learning and Teaching in Higher Education (Goldsmiths, 2018). Dr McKnight’s research lies at the intersection of Science and Technology Studies (STS), Black Feminist Hauntology, and participatory methodologies. She investigates how crises such as antimicrobial resistance (AMR), environmental collapse, and political inequity shape health futures. A key contribution is her conceptualisation of the HIV diaspora , which captures the transnational care experiences of people living with HIV in high-resource settings. Her work critically examines the entanglements of race, infectious disease, and political uncertainty using speculative and sensory methods. Her recent publications and research projects reveal a strong focus on maternal morbidity, speculative futures in sexual health, and the social justice dimensions of AMR. She employs arts-based and collaborative methods to explore the 'unsayable' in healthcare experiences. Nominated for Education Awards 2024 Nominated for Education Awards 2025 Dr McKnight is actively involved in supervising student research and has taught courses such as 'Doing Social Research', 'Health across the Lifecourse', and 'Sociology Research Proposal'. She is a Co-Investigator on the AHRC-funded project 'Reproductive Borders and Bordering Reproduction' and collaborates with the Wellcome Trust-funded project 'Inequalities and Tackling Antimicrobial Resistance in Sexual Health'. She has also secured a grant from the National Institute for Health Research for an arts-based workshop on 'unsayable' experiences. She is actively engaged in academic and public discourse through invited talks, conference presentations, and peer review for journals including Sociology of Health and Illness and Journal of the International AIDS Society .

Thomas G. Costantinoمشاهده پروفایل

استاد

• Emergency Medicine Ultrasound
• Diagnostic Imaging
• Point-of-Care Ultrasound (POCUS)
• +۳ مورد دیگر

Thomas G. Costantino, MD, is a Professor in the Department of Emergency Medicine at Lewis Katz School of Medicine at Temple University. He specializes in Emergency Medicine Ultrasound, with a focus on diagnostic imaging, vascular access, and musculoskeletal ultrasound. Dr. Costantino has held academic positions at multiple institutions, including Drexel University and Medical College of Pennsylvania, and has received numerous accolades for teaching excellence and research contributions. Education: MD from University of Michigan School of Medicine Training: Fellowship and Residency in Emergency Medicine at Medical College of Pennsylvania His research involves advancing point-of-care ultrasound (POCUS) techniques in emergency diagnostics, particularly for aortic dissections, pleural effusions, and acute visual complaints. His publications highlight the efficacy of ultrasound-guided procedures over traditional methods. Scientific Awards & Memberships National Alzheimer’s Federation Research Award University of Michigan Alumni Merit Scholarship Excellence in Teaching Awards at Temple, Drexel, and MCP/Hahnemann Medical Schools Fellow of American Academy of Emergency Medicine and American College of Emergency Physicians Dr. Costantino actively contributes to emergency medicine education, including associate editor roles in medical textbooks and ultrasound training programs. His work emphasizes improving diagnostic accuracy and patient outcomes through innovative imaging techniques.

• Machine Learning
• Data Analytics
• Biomechanics
• +۴ مورد دیگر

Björn Eskofier is a Principal Investigator for the Translational Digital Health Group at AI for Health and leads the research group at Helmholtz Zentrum Munich. He is Professor at Friedrich-Alexander-University Erlangen-Nuremberg (FAU), where he founded the Machine Learning and Data Analytics (MaD) Lab in 2013 and established the Department of Artificial Intelligence in Biomedical Engineering (AIBE). Education: PhD in Biomechanics (University of Calgary, 2006-2013), MSc in Electrical Engineering (FAU, 2006). His research focuses on building a Digital Health Ecosystem through multidisciplinary collaboration, emphasizing Machine Learning, Data Analytics, Biomechanics , and AI-driven clinical translation. Recent publications highlight his work in federated health data systems, predictive disease modeling, and digital symptom monitoring. He is an active academic leader , serving as Area Editor for IEEE journals, General Chair of BHI 2023, and co-director of the EmpkinS initiative. His awards include the Unipreneurs award (2023), multiple best paper prizes, and recognition as a Heisenberg Professor (DFG, 2017-2022).

Joanne Wangمشاهده پروفایل

استاد

• Blood-brain and blood-csf barriers
• Pharmacokinetics-Pharmacodynamics
• Pharmacology
• +۵ مورد دیگر

Joanne Wang is Professor of Pharmaceutics at the University of Washington School of Pharmacy and an Affiliate Investigator at the Fred Hutchinson Cancer Research Center. She holds additional appointments in multiple research centers including the Obstetric-fetal Pharmacology Research Unit (OPRU), Plein Center for Aging Faculty, and Pharmaceutics Faculty. Her educational background includes: PhD in Pharmaceutical Chemistry, University of California, San Francisco (UCSF) MS in Biochemistry, University of Illinois at Chicago BS in Biochemistry, Peking University Dr. Wang's research focuses on solute carrier (SLC) and ATP-binding cassette (ABC) transporters that shuttle drugs, nutrients, neurotransmitters, and hormones across cell membranes. Her work encompasses elucidating mechanisms and clinical impact of transporters in nutrient and drug disposition and their potential as drug targets. Ongoing projects include identification and functional characterization of transporters in human placenta, mechanisms of drug secretion into breastmilk using PBPK modeling, and investigation of transporters in the disposition of meta-iodobenzylguanidine for cancer therapy. Analysis of her recent publications reveals a strong emphasis on transporter-mediated drug disposition in special populations, particularly during pregnancy and lactation, and at the blood-brain barrier. Her work spans from basic transporter characterization to clinical applications, with increasing focus on translational aspects including PBPK modeling and clinical implications of transporter polymorphisms. Dr. Wang is actively involved in mentoring, as evidenced by her lab accepting students. Her research has been supported by significant grants including a UC2 grant from NICHD for placental transporter research. Her multidisciplinary approach integrates in vitro models, in vitro-in vivo extrapolation, and PBPK modeling to address critical questions in drug disposition. She is affiliated with several research centers including the Obstetric-fetal Pharmacology Research Unit (OPRU), Plein Center for Aging, and the Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH), reflecting the breadth and impact of her work across multiple domains of pharmacology and therapeutics.